Eight biotech companies are making significant strides in breast cancer treatment, with innovative approaches and therapies showing promise in clinical trials. Arvinas, BioNTech, Carrick Therapeutics, Context Therapeutics, Hummingbird Bioscience, Oncolytics Biotech, Olema Pharmaceuticals, and Relay Therapeutics are among the companies pushing the boundaries of cancer treatment, offering new hope for patients and their families. In…
cancer on The Soothsayer / page 3
Researchers in Switzerland have made a significant breakthrough in cancer treatment by developing a hybrid approach that combines ultrahigh-dose-rate (UHDR) electron beams with conventional dose-rate (CDR) photon beams. This innovative technique, known as FLASH radiotherapy, has the potential to spare healthy tissues while effectively targeting malignant tumour cells. The study, published in Radiotherapy and Oncology,…
The biotech industry is witnessing a surge in the development of exosome therapy companies, which are harnessing the potential of these tiny vesicles to treat a range of diseases, including cancer, neurological disorders, and inflammatory diseases. With several companies advancing their candidates through clinical trials, the global exosome therapeutics market is expected to grow significantly…
A team of researchers from the USA and Cameroon has developed a non-invasive device that can detect malaria without requiring a single drop of blood. The device, called Cytophone, uses photoacoustic flow cytometry to rapidly identify malaria-infected red blood cells. Initial testing in 30 Cameroonian adults diagnosed with uncomplicated malaria showed promising results, with 95%…
A recent surge in interest in T cell engagers, a type of antibody engineered to redirect the immune system’s T cells to recognize and kill cancer cells, suggests that this field is set to take off. Several biotech companies have launched specifically to develop these medicines, and big names in the industry are investing in…
The biotech industry is witnessing a surge in the development of GPCR (G protein-coupled receptor) therapies, with eight promising biotechs acquiring funding to fortify their pipelines. These biotechs are working on various GPCR-targeted drugs to address numerous diseases, including neuropathic pain, cancer, and metabolic disorders. The market for GPCR drugs is expected to grow significantly,…
Nanotechnology is transforming the healthcare industry with its potential to revolutionize drug delivery, diagnostics, and treatment of various diseases. Eight companies, including Sona Nanotech, Nanobiotix, and ARIZ Precision Medicine, are at the forefront of this revolution, developing innovative nanotechnology-based solutions for cancer treatment, autoimmune diseases, and other conditions. These companies are leveraging nanotechnology to create…
A new wave of biomimicry companies is harnessing the power of nature to develop innovative treatments for various diseases. By studying the properties of plants and animals, these companies are creating novel therapeutic targets and drugs that mimic natural protective mechanisms. From tick saliva to snake venom, these biomimicry companies are unlocking the secrets of…
The biopharma industry is witnessing a surge in investment in the immunology field, with over 10 buyouts of immunology and inflammation (I&I) drug developers this year. Several biotech companies have raised impressive funds to advance the development of their immunology-related research and development (R&D). These companies are working on innovative treatments for various diseases, including…
